Last Updated: August 10, 2026

Nesher Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NESHER PHARMS

NESHER PHARMS has thirty-three approved drugs.

There is one tentative approval on NESHER PHARMS drugs.

Summary for Nesher Pharms

US Patents:	0
Tradenames:	24
Ingredients:	22
NDAs:	33

Drugs and US Patents for Nesher Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nesher Pharms	METOPROLOL SUCCINATE	metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	077779-001	Mar 20, 2008		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Nesher Pharms	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	210080-002	Jul 17, 2019		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Nesher Pharms	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	210080-004	Jul 17, 2019		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Nesher Pharms	BENZONATATE	benzonatate	CAPSULE;ORAL	040795-002	Oct 31, 2007		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Nesher Pharms	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040364-001	Apr 10, 2002		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Nesher Pharms	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	075609-004	Oct 18, 2000		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Nesher Pharms

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Nesher Pharms	MICRO-K	potassium chloride	CAPSULE, EXTENDED RELEASE;ORAL	018238-001	Approved Prior to Jan 1, 1982	4,259,315	⤷ Start Trial
Nesher Pharms	MICRO-K 10	potassium chloride	CAPSULE, EXTENDED RELEASE;ORAL	018238-002	May 14, 1984	4,259,315	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Nesher Pharms

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.